ArticleCell reports. Medicine2023

A phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab in patients with advanced solid tumors.

Sophia Frentzas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.